![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Second-Line Therapy in Refractory Pancreatic Cancer. Results of a Phase II Study
Publisher: Karger
E-ISSN: 2296-5262|32|3|99-102
ISSN: 2296-5270
Source: Oncology Research and Treatment, Vol.32, Iss.3, 2009-02, pp. : 99-102
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract